Heading to #ISTH2026? We look forward to sharing new research in hemophilia at the congress. Here is a snapshot of our oral presentations. Feel free to stop by booth #907 to engage with the Novo Nordisk medical team. Visit ISTH congress program for more details: www.isthcongress.org/program

Heading to #ISTH26? Hear what Emily Waters, U.S. Medical Director of Rare Bleeding Disorders, is looking forward to at this year’s meeting. Visit us at Booth #907 to discuss advances in FVIIIa mimetic design and hemophilia A care. #Hematology #Hemophilia #RareDisease

Studied over decades. Backed by research. Committed to patients for over 100 years. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

Reaffirming our commitment to the T2D community: a new insulin treatment option is now FDA-approved. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

AANP 2026 is almost here! We’re excited to be part of the largest NP conference of the year, bringing together leaders and clinicians committed to continuing education, collaboration, and advancing practice.​ We look forward to the conversations and opportunities ahead.​ #AANP #AANP2026

Happy Men’s Health Day from Novo Nordisk 💙​ Men’s health matters and it is important to encourage action. HCPs play a key role in assessing risks, developing an action plan, and encouraging patients to prioritize their cardiometabolic health.​ #MensHealthDay #NovoNordisk

On #WorldSickleCellDay, we reflect on how much more there is to understand about this complex #BloodDisorder. Hear Dr. Sharl Azar share his thoughts on what remains to be understood and how HCPs can advocate for those they care for. Watch the video here: www.novonordiskmedical.com/therapeutic-...

Building on more than a century of progress in insulin treatments. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

Thank you to everyone who made #FSCDR2026 such a meaningful meeting. We appreciated the opportunity to engage in scientific dialogue and share perspectives on #SickleCellDisease and #RedBloodCell health. Visit sciencehub.novonordisk.com/congresses/f... for Novo Nordisk congress resources.

We are pleased to share that three abstracts from Novo Nordisk have been accepted for oral presentation at #FSCDR2026. We look forward to engaging with the scientific community on these data and continuing the dialogue to address unmet needs in #SickleCellDisease #ClinicalResearch #RWE #Hematology

We’re looking forward to the #FSCDR2026 Annual Meeting (June 5–7). Our Medical Affairs team is excited to engage in scientific dialogue on #SickleCellDisease and the role of red blood cell health in advancing patient care.

Novo Nordisk Medical Affairs will be at ADA in New Orleans! Connect with our team by visiting Medical Booth 1619. We’re looking forward to engaging with the scientific community in attendance! #ADASciSessions #ADA2026 #Diabetes #Obesity

Phase 3 trial results in type 2 diabetes, see more: bit.ly/3PsEqH4 #Type2Diabetes #T2D

As #AAPA2026 comes to a close, we want to thank the physician assistant community for your dedication to supporting patient care particularly in areas of high national priority such as diabetes and obesity.​

At Novo Nordisk Medical Affairs, we recognize the essential role PAs play in supporting high‑quality patient care, aligned with national health priorities such as diabetes and obesity. Looking forward to a week of dialogue, collaboration, and scientific exchange at #AAPA2026​

A treatment for adult patients at elevated risk for CV events with type 2 diabetes is available. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

At Novo Nordisk, we are committed to helping women live their healthiest lives and achieve the best health today and every day. #NationalWomensHealthDay #WomenHealth #Diabetes #Obesity #CardiometabolicHealth #RareDiseases

Thank you to everyone who connected with Novo Nordisk Medical Affairs at #SCM26 in New Orleans. Great conversations and collaboration.

As NKF Spring Clinical Meetings 2026 concludes, we remain committed to continued education, collaboration, and shared learning across the kidney community. Thank you to the National Kidney Foundation and the broader community for meaningful engagement throughout the meeting.​ #KidneyHealth

We are excited to share that Novo Nordisk Medical Affairs will be at #SCM26 National Kidney Foundation- Advancing Education Across Kidney Care in New Orleans! Looking forward to connecting with colleagues and advancing kidney care.

Novo Nordisk Medical Affairs celebrates nurses not just this week, but every week for the expertise, care, and steadfast support you provide to patients every day. Thank you for your dedication, teamwork, and compassion. We recognize and appreciate your critical role in advancing health.​

A once-daily oral option to help support individualized care in adult patients with type 2 diabetes is here. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

Grateful for the conversations at #PES2026. Thank you for taking time to connect with our medical team. Looking forward to continuing the dialogue. Visit sciencehub.novonordisk.com/congresses/p... for more resources. #PediatricEndocrinology #GrowthDisorders

A once-daily oral option for adult patients with type 2 diabetes is FDA approved. For more information, please visit: www.novonordiskmedical.com/therapeutic-...

Our medical team is looking forward to the #PediatricEndocrineSociety #PES2026 Annual Meeting in San Francisco (30 April–3 May). If you’re attending, we’d welcome the chance to connect and engage in scientific dialogue. #Growthdisorders

Weight loss is associated with health impacts far beyond what patients see on the scale. Visit www.novonordiskmedical.com/therapeutic-... to learn more.

Patients with obesity are at an increased risk of several cardiometabolic risk factors. Discover more information at www.novonordiskmedical.com/therapeutic-...

On World Hemophilia Day, we reaffirm our commitment to the hemophilia community. Today, we share Shellye's story, emphasizing the need to recognize this rare bleeding disorder across its full clinical spectrum. For the full video, visit bit.ly/48qWZ4N. #WHD2026 Intended for US HCPs Only.

For patients with obesity, taking action can be life-saving. Visit www.novonordiskmedical.com/therapeutic-... to learn more.

The link between obesity and CVD is clear. Explore Novo Nordisk’s latest insights at www.novonordiskmedical.com/therapeutic-...

Bringing Bluesky the latest updates from Novo Nordisk Medical Affairs.

Please see our community guidelines. All content is intended for U.S. Healthcare Professionals only and is non-promotional in nature. For more information, visit www.novonordiskmedical.com.